These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4843169)

  • 21. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
    Snyder SH
    Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of d-amphetamine on spontaneous and stimulation-induced release of catecholamines.
    Farnebo LO
    Acta Physiol Scand Suppl; 1971; 371():45-52. PubMed ID: 4112832
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo release of newly synthesized catecholamines from the hypothalamus by amphetamine.
    Philippu A; Glowinski J; Besson MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(1):1-8. PubMed ID: 4275627
    [No Abstract]   [Full Text] [Related]  

  • 24. Characteristics of amphetamine-induced release of norepinephrine from rat cerebral cortex in vitro.
    Ziance RJ; Azzaro AJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Aug; 182(2):284-94. PubMed ID: 5048365
    [No Abstract]   [Full Text] [Related]  

  • 25. Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo.
    Chiueh CC; Moore KE
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):189-99. PubMed ID: 4811449
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
    Chiueh CC; Moore KE
    J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
    [No Abstract]   [Full Text] [Related]  

  • 29. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 30. Depletion of hypothalamic norepinephrine by food deprivation and interaction with D-amphetamine.
    Glick SD; Waters DH; Milloy S
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):775-8. PubMed ID: 4750114
    [No Abstract]   [Full Text] [Related]  

  • 31. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of para-methoxyamphetamine on catecholamine metabolism in the mouse brain.
    Hitzemann RJ; Loh HH; Domino EF
    Life Sci I; 1971 Oct; 10(19):1087-95. PubMed ID: 5132700
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):328-36. PubMed ID: 581027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL; Berkowitz AL; Regenstein AC
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.
    Walters JR; Roth RH; Aghajanian GK
    J Pharmacol Exp Ther; 1973 Sep; 186(3):630-9. PubMed ID: 4728341
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
    Smith DG; Geis LS; Lyness WH
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):293-8. PubMed ID: 6085821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and biochemical effects of d-and 1-amphetamine on central catecholamine neurons.
    Svensson TH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(2):170-80. PubMed ID: 4257153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.